Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to $938000.0.

  • Nexgel's Cash & Equivalents fell 1142.59% to $938000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $938000.0, marking a year-over-year decrease of 1142.59%. This contributed to the annual value of $1.8 million for FY2024, which is 3307.41% down from last year.
  • According to the latest figures from Q3 2025, Nexgel's Cash & Equivalents is $938000.0, which was down 1142.59% from $725000.0 recorded in Q2 2025.
  • In the past 5 years, Nexgel's Cash & Equivalents ranged from a high of $13.4 million in Q4 2021 and a low of $382000.0 during Q2 2021
  • Moreover, its 5-year median value for Cash & Equivalents was $1.3 million (2021), whereas its average is $2.8 million.
  • Per our database at Business Quant, Nexgel's Cash & Equivalents soared by 4161875.0% in 2021 and then plummeted by 9251.9% in 2023.
  • Quarter analysis of 5 years shows Nexgel's Cash & Equivalents stood at $13.4 million in 2021, then crashed by 91.75% to $1.1 million in 2022, then surged by 145.23% to $2.7 million in 2023, then crashed by 33.07% to $1.8 million in 2024, then crashed by 48.09% to $938000.0 in 2025.
  • Its Cash & Equivalents was $938000.0 in Q3 2025, compared to $725000.0 in Q2 2025 and $1.2 million in Q1 2025.